AT359196B - Verfahren zur herstellung von arzneiformen zur enteralen verabreichung - Google Patents
Verfahren zur herstellung von arzneiformen zur enteralen verabreichungInfo
- Publication number
- AT359196B AT359196B AT510975A AT510975A AT359196B AT 359196 B AT359196 B AT 359196B AT 510975 A AT510975 A AT 510975A AT 510975 A AT510975 A AT 510975A AT 359196 B AT359196 B AT 359196B
- Authority
- AT
- Austria
- Prior art keywords
- production
- enteral administration
- medicinal forms
- medicinal
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH920474 | 1974-07-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA510975A ATA510975A (de) | 1980-03-15 |
| AT359196B true AT359196B (de) | 1980-10-27 |
Family
ID=4349465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT510975A AT359196B (de) | 1974-07-04 | 1975-07-03 | Verfahren zur herstellung von arzneiformen zur enteralen verabreichung |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5132722A (de) |
| AT (1) | AT359196B (de) |
| AU (1) | AU507674B2 (de) |
| BE (1) | BE831041A (de) |
| CA (1) | CA1057196A (de) |
| DE (1) | DE2528257C2 (de) |
| ES (1) | ES439074A1 (de) |
| FR (1) | FR2276833A1 (de) |
| GB (1) | GB1513383A (de) |
| HK (1) | HK17281A (de) |
| HU (1) | HU172531B (de) |
| IE (1) | IE41573B1 (de) |
| IL (1) | IL47623A (de) |
| MY (1) | MY8100372A (de) |
| NL (1) | NL7507745A (de) |
| PH (1) | PH13763A (de) |
| SE (1) | SE436831B (de) |
| ZA (1) | ZA754303B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
| DE2707878C2 (de) * | 1977-02-24 | 1986-01-30 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren |
| DK154607C (da) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
| JPS56104813A (en) * | 1980-01-25 | 1981-08-20 | Takeda Chem Ind Ltd | Composition for rectal infusion containing compound having beta-lactam ring |
| AU543727B2 (en) | 1980-06-02 | 1985-05-02 | Ayerst Mckenna & Harrison Inc. | Injectable composition of rapamycin |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| DE3829643A1 (de) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit |
-
1975
- 1975-06-25 DE DE2528257A patent/DE2528257C2/de not_active Expired
- 1975-06-27 SE SE7507413A patent/SE436831B/sv not_active IP Right Cessation
- 1975-06-30 NL NL7507745A patent/NL7507745A/xx not_active Application Discontinuation
- 1975-06-30 GB GB27470/75A patent/GB1513383A/en not_active Expired
- 1975-07-02 IE IE1468/75A patent/IE41573B1/en unknown
- 1975-07-02 PH PH17338A patent/PH13763A/en unknown
- 1975-07-02 ES ES439074A patent/ES439074A1/es not_active Expired
- 1975-07-02 IL IL47623A patent/IL47623A/xx unknown
- 1975-07-02 HU HU75SA00002815A patent/HU172531B/hu not_active IP Right Cessation
- 1975-07-03 FR FR7520947A patent/FR2276833A1/fr active Granted
- 1975-07-03 AT AT510975A patent/AT359196B/de not_active IP Right Cessation
- 1975-07-03 AU AU82736/75A patent/AU507674B2/en not_active Expired
- 1975-07-03 JP JP50081486A patent/JPS5132722A/ja active Pending
- 1975-07-03 CA CA230,702A patent/CA1057196A/en not_active Expired
- 1975-07-04 ZA ZA754303A patent/ZA754303B/xx unknown
- 1975-07-04 BE BE158021A patent/BE831041A/xx not_active IP Right Cessation
-
1981
- 1981-04-30 HK HK172/81A patent/HK17281A/xx unknown
- 1981-12-30 MY MY372/81A patent/MY8100372A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1057196A (en) | 1979-06-26 |
| IE41573L (en) | 1976-01-04 |
| GB1513383A (en) | 1978-06-07 |
| ATA510975A (de) | 1980-03-15 |
| NL7507745A (nl) | 1976-01-06 |
| HK17281A (en) | 1981-05-08 |
| FR2276833B1 (de) | 1978-11-10 |
| IE41573B1 (en) | 1980-01-30 |
| DE2528257C2 (de) | 1986-02-13 |
| PH13763A (en) | 1980-09-18 |
| SE7507413L (sv) | 1976-01-05 |
| BE831041A (fr) | 1976-01-05 |
| FR2276833A1 (fr) | 1976-01-30 |
| JPS5132722A (de) | 1976-03-19 |
| AU507674B2 (en) | 1980-02-21 |
| SE436831B (sv) | 1985-01-28 |
| DE2528257A1 (de) | 1976-01-22 |
| ES439074A1 (es) | 1977-05-16 |
| HU172531B (hu) | 1978-09-28 |
| IL47623A0 (en) | 1975-10-15 |
| IL47623A (en) | 1979-05-31 |
| MY8100372A (en) | 1981-12-31 |
| AU8273675A (en) | 1977-01-06 |
| ZA754303B (en) | 1977-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT326270B (de) | Verfahren zur herstellung von arzneiformen | |
| ATA939775A (de) | Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten | |
| DD129648A5 (de) | Verfahren zur herstellung von prostaglandinderivaten | |
| AT363889B (de) | Verfahren zur herstellung von enzympraeparaten | |
| AT366576B (de) | Verfahren zur herstellung von pharmazeutischen praeparaten | |
| AT329780B (de) | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten | |
| ATA916173A (de) | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten | |
| AT333448B (de) | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten | |
| AT344317B (de) | Verfahren zur herstellung von arzneipraeparaten | |
| AT359196B (de) | Verfahren zur herstellung von arzneiformen zur enteralen verabreichung | |
| AT306228B (de) | Verfahren zur Herstellung pharmazeutischer Zubereitungen | |
| AT333749B (de) | Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten | |
| AT361630B (de) | Verfahren zur herstellung von arzneimitteln | |
| AT342191B (de) | Verfahren zur herstellung von arzneimittelkombinationen | |
| AT340048B (de) | Verfahren zur herstellung von penicillin- und cephalosporinsaure-derivaten | |
| AT309690B (de) | Verfahren zur Herstellung einer verbesserten oralen Applikationsform von Raubasin | |
| AT342205B (de) | Verfahren zur herstellung von arzneimittelkugelchen | |
| AT359215B (de) | Verfahren zur herstellung von pgfbeta-prosta- glandinen | |
| AT309431B (de) | Verfahren zur Herstellung von neuen Tetrahydropyridinderivaten sowie von Säureadditionssalzen dieser Verbindungen | |
| AT337717B (de) | Verfahren zur herstellung von halogenathanphosphonsauredihalogeniden und vinylphosphonsauredihalogeniden | |
| AT347469B (de) | Verfahren zur herstellung von benzodiazepin- derivaten | |
| AT335063B (de) | Verfahren zur herstellung von d(-)-alfa-amino-p-hydroxybenzylpenicillin | |
| AT348680B (de) | Verfahren zur herstellung von arzneipraeparaten | |
| AT358569B (de) | Verfahren zur herstellung von 2-aminomethyl- pyrrolidin und dessen saeureadditionssalzen | |
| ATA517075A (de) | Verfahren zur herstellung von neuen 3- acylamino-2-azetidinonderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |